U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 235

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:201063077
GRCh38:
Chr1:201093949
CACNA1SMalignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely benign
(Mar 23, 2022)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr1:201054177
GRCh38:
Chr1:201085049
CACNA1SMalignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr1:201038344
GRCh38:
Chr1:201069216
CACNA1SMalignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely benign
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr1:201052336
GRCh38:
Chr1:201083208
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr1:201031657
GRCh38:
Chr1:201062529
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Likely benign
(Feb 7, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr1:201061082
GRCh38:
Chr1:201091954
CACNA1SThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Jun 20, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr1:201060929
GRCh38:
Chr1:201091801
CACNA1SThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Mar 12, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr1:201016638
GRCh38:
Chr1:201047510
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Aug 7, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr1:201023663
GRCh38:
Chr1:201054535
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr1:201023706
GRCh38:
Chr1:201054578
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(May 2, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr1:201018118
GRCh38:
Chr1:201048990
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr1:201021695
GRCh38:
Chr1:201052567
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Apr 6, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr1:201022421
GRCh38:
Chr1:201053293
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr1:201058369
GRCh38:
Chr1:201089241
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Jun 26, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr1:201063163
GRCh38:
Chr1:201094035
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Jun 28, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr1:201023707
GRCh38:
Chr1:201054579
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Aug 9, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr1:201009430
GRCh38:
Chr1:201040302
CACNA1S, LOC101929305P1767SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr1:201054159
GRCh38:
Chr1:201085031
CACNA1SG384EHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Inborn genetic diseases,
Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr1:201009006
GRCh38:
Chr1:201039878
CACNA1S, LOC101929305D1859NHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jul 11, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr1:201046097
GRCh38:
Chr1:201076969
CACNA1SR593QMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Sep 28, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr1:201058579
GRCh38:
Chr1:201089451
CACNA1ST236MMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Oct 8, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr1:201044743
GRCh38:
Chr1:201075615
CACNA1SV610LMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases
Uncertain significance
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr1:201047212-201047225
GRCh38:
Chr1:201078084-201078097
CACNA1SN468fsHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Pathogenic/Likely pathogenic
(Feb 2, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr1:201052449
GRCh38:
Chr1:201083321
CACNA1SR412*Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Pathogenic/Likely pathogenic
(May 25, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr1:201047096
GRCh38:
Chr1:201077968
CACNA1SE510DHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
26.
GRCh37:
Chr1:201013457
GRCh38:
Chr1:201044329
CACNA1SR1599QHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr1:201054591
GRCh38:
Chr1:201085463
CACNA1SV375FHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Oct 25, 2021)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr1:201047196
GRCh38:
Chr1:201078068
CACNA1ST477IHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr1:201034948
GRCh38:
Chr1:201065820
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
30.
GRCh37:
Chr1:201010665
GRCh38:
Chr1:201041537
CACNA1S, LOC101929305G1701RMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1
Uncertain significance
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr1:201031053
GRCh38:
Chr1:201061925
CACNA1SThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Oct 23, 2021)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:201046094
GRCh38:
Chr1:201076966
CACNA1SR594LThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jun 28, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr1:201022636
GRCh38:
Chr1:201053508
CACNA1SR1249QThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Inborn genetic diseases,
not provided
Conflicting interpretations of pathogenicity
(Aug 15, 2022)
criteria provided, conflicting interpretations
34.
GRCh37:
Chr1:201054106
GRCh38:
Chr1:201084978
CACNA1SA402SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jul 5, 2023)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr1:201063068
GRCh38:
Chr1:201093940
CACNA1SQ114KHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Jul 21, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr1:201058480
GRCh38:
Chr1:201089352
CACNA1SN269SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Feb 5, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr1:201043740
GRCh38:
Chr1:201074612
CACNA1SL653FHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Mar 8, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr1:201035046
GRCh38:
Chr1:201065918
CACNA1SI925VHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Inborn genetic diseases,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jun 27, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr1:201021680
GRCh38:
Chr1:201052552
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Feb 8, 2023)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr1:201016671
GRCh38:
Chr1:201047543
CACNA1SV1509IHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Oct 23, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr1:201017736
GRCh38:
Chr1:201048608
CACNA1SR1472HThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not provided
Conflicting interpretations of pathogenicity
(Aug 9, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr1:201047074
GRCh38:
Chr1:201077946
CACNA1SA518TThyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
not provided
Uncertain significance
(Sep 12, 2021)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr1:201030583
GRCh38:
Chr1:201061455
CACNA1SA1023TMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
not provided, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Aug 28, 2023)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr1:201031203
GRCh38:
Chr1:201062075
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Benign/Likely benign
(Oct 28, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr1:201020104-201020105
GRCh38:
Chr1:201050976-201050977
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr1:201035053
GRCh38:
Chr1:201065925
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr1:201031648
GRCh38:
Chr1:201062520
CACNA1SThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr1:201009187
GRCh38:
Chr1:201040059
CACNA1S, LOC101929305Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Likely benign
(Apr 24, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr1:201018237
GRCh38:
Chr1:201049109
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Apr 30, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr1:201052381
GRCh38:
Chr1:201083253
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr1:201035454
GRCh38:
Chr1:201066326
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Likely benign
(Aug 29, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr1:201039490
GRCh38:
Chr1:201070362
CACNA1SR757QMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr1:201058451
GRCh38:
Chr1:201089323
CACNA1SG279SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1,
not provided
Conflicting interpretations of pathogenicity
(Sep 1, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr1:201079386
GRCh38:
Chr1:201110258
CACNA1ST55MMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Nov 18, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr1:201020200
GRCh38:
Chr1:201051072
CACNA1SS1342LMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, not provided
Uncertain significance
(Oct 8, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr1:201036025
GRCh38:
Chr1:201066897
CACNA1SM883LHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Mar 26, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr1:201039487
GRCh38:
Chr1:201070359
CACNA1SP758LHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr1:201017737
GRCh38:
Chr1:201048609
CACNA1SR1472CHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jul 5, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr1:201079286
GRCh38:
Chr1:201110158
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr1:201036042
GRCh38:
Chr1:201066914
CACNA1SA877VHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Sep 20, 2022)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr1:201034960
GRCh38:
Chr1:201065832
CACNA1SHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(May 24, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr1:201052406
GRCh38:
Chr1:201083278
CACNA1SH426RHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
not provided, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Oct 25, 2021)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr1:201021765
GRCh38:
Chr1:201052637
CACNA1SK1291NHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr1:201030513
GRCh38:
Chr1:201061385
CACNA1SI1046Nnot provided, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Jun 13, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr1:201009200
GRCh38:
Chr1:201040072
CACNA1S, LOC101929305R1794QHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Sep 3, 2022)
criteria provided, conflicting interpretations
66.
GRCh37:
Chr1:201018231
GRCh38:
Chr1:201049103
CACNA1SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1
Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr1:201028388
GRCh38:
Chr1:201059260
CACNA1SI1152VHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr1:201039515
GRCh38:
Chr1:201070387
CACNA1SE749KHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr1:201036117
GRCh38:
Chr1:201066989
CACNA1ST852MHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr1:201034997
GRCh38:
Chr1:201065869
CACNA1SM941THypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Aug 20, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr1:201041946
GRCh38:
Chr1:201072818
CACNA1SI722VHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Mar 9, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr1:201022637
GRCh38:
Chr1:201053509
CACNA1SR1249WThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Uncertain significance
(May 24, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr1:201035070
GRCh38:
Chr1:201065942
CACNA1SV917MThyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Uncertain significance
(Aug 14, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr1:201058586
GRCh38:
Chr1:201089458
CACNA1SV234MHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr1:201046215
GRCh38:
Chr1:201077087
CACNA1SN554DHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr1:201021733
GRCh38:
Chr1:201052605
CACNA1SR1302QHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Uncertain significance
(Jul 21, 2023)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr1:201047119
GRCh38:
Chr1:201077991
CACNA1SV503MHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr1:201047107
GRCh38:
Chr1:201077979
CACNA1SG507SMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Jun 28, 2022)
criteria provided, conflicting interpretations
79.
GRCh37:
Chr1:201036025
GRCh38:
Chr1:201066897
CACNA1SM883VMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr1:201081454
GRCh38:
Chr1:201112326
CACNA1SS5LMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1
Uncertain significance
(Aug 15, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr1:201029866
GRCh38:
Chr1:201060738
CACNA1SW1112GMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Inborn genetic diseases,
Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr1:201044687
GRCh38:
Chr1:201075559
CACNA1SHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Aug 27, 2022)
criteria provided, conflicting interpretations
83.
GRCh37:
Chr1:201013548
GRCh38:
Chr1:201044420
CACNA1SE1569KHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr1:201009492
GRCh38:
Chr1:201040364
CACNA1S, LOC101929305V1746AThyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr1:201061110
GRCh38:
Chr1:201091982
CACNA1SHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr1:201029944
GRCh38:
Chr1:201060816
CACNA1SR1086GHypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Dec 7, 2021)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr1:201058520
GRCh38:
Chr1:201089392
CACNA1SI256VHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, not specified,
Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Jun 30, 2023)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr1:201079325
GRCh38:
Chr1:201110197
CACNA1SHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, not provided, Malignant hyperthermia, susceptibility to, 5,
Hypokalemic periodic paralysis, type 1
Benign/Likely benign
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr1:201016695
GRCh38:
Chr1:201047567
CACNA1ST1501AHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Aug 30, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr1:201013595
GRCh38:
Chr1:201044467
CACNA1SHypokalemic periodic paralysis, type 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, not provided, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr1:201058502
GRCh38:
Chr1:201089374
CACNA1SR262WMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr1:201035025
GRCh38:
Chr1:201065897
CACNA1SV932MThyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Sep 20, 2022)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr1:201044652
GRCh38:
Chr1:201075524
CACNA1SY640CThyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Uncertain significance
(Feb 12, 2022)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr1:201052338
GRCh38:
Chr1:201083210
CACNA1SI449VMalignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, Thyrotoxic periodic paralysis, susceptibility to, 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1, not provided
Conflicting interpretations of pathogenicity
(Aug 15, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr1:201016261
GRCh38:
Chr1:201047133
CACNA1SK1550NThyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Uncertain significance
(Sep 24, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr1:201030484
GRCh38:
Chr1:201061356
CACNA1SM1056VThyrotoxic periodic paralysis, susceptibility to, 1, Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1,
Malignant hyperthermia, susceptibility to, 5, Hypokalemic periodic paralysis, type 1
Conflicting interpretations of pathogenicity
(Aug 10, 2022)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr1:201061232
GRCh38:
Chr1:201092104
CACNA1SV137MHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr1:201063072
GRCh38:
Chr1:201093944
CACNA1SF112LHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(May 12, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr1:201063104
GRCh38:
Chr1:201093976
CACNA1SA102TInborn genetic diseases, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5,
Thyrotoxic periodic paralysis, susceptibility to, 1, Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Conflicting interpretations of pathogenicity
(Jul 11, 2022)
criteria provided, conflicting interpretations
100.
GRCh37:
Chr1:201079388
GRCh38:
Chr1:201110260
CACNA1SE54DHypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5, Thyrotoxic periodic paralysis, susceptibility to, 1,
Hypokalemic periodic paralysis, type 1, Malignant hyperthermia, susceptibility to, 5
Uncertain significance
(Jul 25, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination